HEPATIC FUNCTION ABNORMAL
Clinical trials for HEPATIC FUNCTION ABNORMAL explained in plain language.
Never miss a new study
Get alerted when new HEPATIC FUNCTION ABNORMAL trials appear
Sign up with your email to follow new studies for HEPATIC FUNCTION ABNORMAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver health and drug safety: new insights on fexinidazole
Knowledge-focused CompletedThis study tested how a single 1200 mg dose of fexinidazole is processed in 21 adults with mild or moderate liver impairment compared to those with normal liver function. The goal was to understand if liver problems change drug levels in the body, which helps doctors decide on sa…
Matched conditions: HEPATIC FUNCTION ABNORMAL
Phase: PHASE1 • Sponsor: Sanofi • Aim: Knowledge-focused
Last updated May 17, 2026 06:23 UTC
-
Liver health and drug processing: a new study on venglustat
Knowledge-focused CompletedThis study looked at how different levels of liver impairment affect the way the body handles a single dose of the drug venglustat. Researchers compared adults with mild, moderate, or severe liver problems to those with healthy livers. The goal was to understand safety and how th…
Matched conditions: HEPATIC FUNCTION ABNORMAL
Phase: PHASE1 • Sponsor: Sanofi • Aim: Knowledge-focused
Last updated May 06, 2026 16:13 UTC